NPCUF
US OTC
Allon Therapeutics Inc
Overview
NPCUF
Symbol
US OTC
Exchange
About stock

Allon Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing and marketing central nervous system therapies. Its preclinical drug candidate comprises AL-309 for the treatment of peripheral neuropathy. The company was formerly known as Neuro Discovery Inc. and changed its name to Allon Therapeutics Inc. in September 2004.

Allon Therapeutics Inc. is headquartered in Vancouver, Canada.

Allon Therapeutics Inc dividend calculator
Report issue